Core Laboratories N.V.

Core Laboratories N.V. Q2 2025 Earnings Recap

CLB Q2 2025 July 25, 2025

Get alerts when CLB reports next quarter

Set up alerts — free

Core Laboratories reported a 5% sequential revenue increase in Q2 2025, driven by improved demand for lab services and enhanced operating margins across its segments.

Earnings Per Share Beat
$0.19 vs $0.18 est.
+5.6% surprise
Revenue Miss
130159000 vs 130893080 est.
-0.6% surprise

Market Reaction

1-Day +1.88%
5-Day -10.23%
30-Day -3.5%

See CLB alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Revenue reached $130.2 million, with a 7% rise in Reservoir Description and a 3% increase in Production Enhancement compared to Q1.
  • Operating margins improved to 13% in Reservoir Description and 9% in Production Enhancement, reflecting strong demand for high-margin services.
  • Core continued its commitment to shareholder returns, repurchasing over 237,000 shares and reducing net debt by more than $9 million, achieving a leverage ratio of 1.27, the lowest in 8 years.
  • The company remains focused on innovation and geographic expansion while adhering to its financial tenets, including maximizing free cash flow and return on invested capital.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit CLB on AllInvestView.

Get the Full Picture on CLB

Track Core Laboratories N.V. in your portfolio with real-time analytics, dividend tracking, and more.

View CLB Analysis